Organization
Innostellar Biotherapeutics
4 clinical trials
Clinical trial
A Phase 2, Randomized Controlled, Open-Label Study to Establish the Safety and Efficacy of LX102 in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Dose-Escalation Study of LX102 Gene Therapy for Neovascular Age-Related Macular Degeneration (nAMD)Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Multi-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of rAAV2-RPE65 Gene Therapy (LX101) in Subjects With Biallelic RPE65 Mutation-associated Inherited Retinal DystrophyStatus: Active (not recruiting), Estimated PCD: 2023-12-06
Clinical trial
A Clinical Trial to Evaluate the Safety and Efficacy of Subretinal Re-Administration of LX101 to the Contralateral Eye in Subjects With Biallelic RPE65 Mutation-associated Inherited Retinal DystrophyStatus: Recruiting, Estimated PCD: 2024-09-01